ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - BIT:1LLY - US5324571083 - Common Stock
640.4 EUR
-5.4 (-0.84%)
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 49 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
1LLY had positive earnings in the past year.
1LLY had a positive operating cash flow in the past year.
1LLY had positive earnings in each of the past 5 years.
In the past 5 years 1LLY always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 13.67%, 1LLY belongs to the best of the industry, outperforming 87.76% of the companies in the same industry.
With an excellent Return On Equity value of 75.52%, 1LLY belongs to the best of the industry, outperforming 95.92% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 29.63%, 1LLY belongs to the top of the industry, outperforming 93.88% of the companies in the same industry.
1LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 15.25%.
The last Return On Invested Capital (29.63%) for 1LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROIC | 29.63% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
1LLY's Profit Margin of 25.91% is amongst the best of the industry. 1LLY outperforms 89.80% of its industry peers.
1LLY's Profit Margin has declined in the last couple of years.
The Operating Margin of 1LLY (42.13%) is better than 93.88% of its industry peers.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
1LLY has a better Gross Margin (82.64%) than 83.67% of its industry peers.
In the last couple of years the Gross Margin of 1LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
The number of shares outstanding for 1LLY has been reduced compared to 5 years ago.
The debt/assets ratio for 1LLY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.81 indicates that 1LLY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.81, 1LLY belongs to the best of the industry, outperforming 91.84% of the companies in the same industry.
A Debt/Equity ratio of 1.87 is on the high side and indicates that 1LLY has dependencies on debt financing.
With a Debt to Equity ratio value of 1.87, 1LLY is not doing good in the industry: 77.55% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.81 |
ROIC/WACC3.07
WACC9.66%
2.3 Liquidity
1LLY has a Current Ratio of 1.28. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY has a Current ratio (1.28) which is comparable to the rest of the industry.
1LLY has a Quick Ratio of 1.28. This is a bad value and indicates that 1LLY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 1.00, 1LLY perfoms like the industry average, outperforming 55.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.67%, which is quite impressive.
1LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
Looking at the last year, 1LLY shows a very strong growth in Revenue. The Revenue has grown by 36.83%.
1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
3.2 Future
1LLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.30% yearly.
1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.76% yearly.
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.3%
Revenue Next Year36.76%
Revenue Next 2Y27.21%
Revenue Next 3Y23.13%
Revenue Next 5Y17.76%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 46.64, the valuation of 1LLY can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 63.27% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 1LLY to the average of the S&P500 Index (27.27), we can say 1LLY is valued expensively.
Based on the Price/Forward Earnings ratio of 24.68, the valuation of 1LLY can be described as rather expensive.
Based on the Price/Forward Earnings ratio, 1LLY is valued a bit more expensive than the industry average as 61.22% of the companies are valued more cheaply.
1LLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.64 | ||
| Fwd PE | 24.68 |
4.2 Price Multiples
1LLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 67.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 30.8 |
4.3 Compensation for Growth
1LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of 1LLY may justify a higher PE ratio.
1LLY's earnings are expected to grow with 42.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)2.82
EPS Next 2Y53.25%
EPS Next 3Y42.28%
5. Dividend
5.1 Amount
1LLY has a yearly dividend return of 0.79%, which is pretty low.
Compared to an average industry Dividend Yield of 3.04, 1LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, 1LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
5.2 History
On average, the dividend of 1LLY grows each year by 15.60%, which is quite nice.
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 36.46% of its income as dividend. This is a sustainable payout ratio.
1LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP36.46%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
BIT:1LLY (9/12/2025, 7:00:00 PM)
640.4
-5.4 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap606.11B
Analysts80
Price Target771.26 (20.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.79% |
Yearly Dividend4.21
Dividend Growth(5Y)15.6%
DP36.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.94%
Min EPS beat(2)9.38%
Max EPS beat(2)14.51%
EPS beat(4)3
Avg EPS beat(4)2.5%
Min EPS beat(4)-20.34%
Max EPS beat(4)14.51%
EPS beat(8)7
Avg EPS beat(8)31.01%
EPS beat(12)10
Avg EPS beat(12)22.08%
EPS beat(16)12
Avg EPS beat(16)15.86%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)4.72%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)1.54%
PT rev (1m)-8.67%
PT rev (3m)-11.45%
EPS NQ rev (1m)1.79%
EPS NQ rev (3m)3.8%
EPS NY rev (1m)5.23%
EPS NY rev (3m)5.27%
Revenue NQ rev (1m)1.23%
Revenue NQ rev (3m)4.43%
Revenue NY rev (1m)2.8%
Revenue NY rev (3m)3.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.64 | ||
| Fwd PE | 24.68 | ||
| P/S | 13.39 | ||
| P/FCF | N/A | ||
| P/OCF | 65.2 | ||
| P/B | 39.03 | ||
| P/tB | 108.15 | ||
| EV/EBITDA | 30.8 |
EPS(TTM)13.73
EY2.14%
EPS(NY)25.95
Fwd EY4.05%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)9.82
OCFY1.53%
SpS47.82
BVpS16.41
TBVpS5.92
PEG (NY)0.61
PEG (5Y)2.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROCE | 36.25% | ||
| ROIC | 29.63% | ||
| ROICexc | 31.43% | ||
| ROICexgc | 39.29% | ||
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.4 | ||
| Cap/Depr | 580.51% | ||
| Cap/Sales | 20.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 6.81 |
F-Score6
WACC9.66%
ROIC/WACC3.07
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.3%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
Revenue Next Year36.76%
Revenue Next 2Y27.21%
Revenue Next 3Y23.13%
Revenue Next 5Y17.76%
EBIT growth 1Y67.12%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year84.34%
EBIT Next 3Y42.93%
EBIT Next 5Y29.73%
FCF growth 1Y-101.56%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y75.24%
OCF growth 3Y6.69%
OCF growth 5Y12.76%